Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP
NCT01107951
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG:
Rituximab and dexamethasone
Sponsor
Hospital Universitario Dr. Jose E. Gonzalez